International taskforce releases new five-year antimicrobial resistance work plan

Canada, EU, Norway & U.S. also publish 2016-2020 accomplishments report

Transatlantic Taskforce on Antimicrobial Resistance Accelerates International Fight Against AMR And Welcomes UK as New Member

The Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)—which includes Canada, the European Union, Norway, and the United States—is launching its fourth implementation phase since 2009 to continue combating antimicrobial resistance (AMR). The 2021-2026 draft work plan includes new collaboration areas such as sewage-based surveillance, modeling transmission of AMR pathogens, and diagnostic stewardship. The Taskforce is also pleased to welcome the United Kingdom, another global leader in the fight against AMR, as its newest member.   Collaboration across the TATFAR member agencies in the last 12 years has enhanced synergy and communication, leading to strengthened domestic and global efforts to combat the urgent global threat of AMR.

Recent successes include: Publishing a resource summarizing data sources to quantify antimicrobial use in human healthcare, for public health agencies, governments, and other stakeholders interested in assessing antimicrobial use. Collaborating to produce three manuscripts (pending publication) addressing point-prevalence survey (PPS) methods and PPS data use for hospitals and long-term care facilities/nursing homes. Publishing papers summarizing economic incentives for antibacterial drug development.

Read the full 2016-2020 Progress Report

In the next implementation period, TATFAR will continue to collaborate and share best practices that strengthen domestic and global efforts across four key areas: Appropriate antimicrobial use in human and veterinary medicine Surveillance and prevention of AMR Strategies to improve financial incentives, access, research, and development of antimicrobial drugs, diagnostics, and alternatives Cross-cutting actions to improve awareness about AMR and appropriate use of antibiotics, and to disseminate information from TATFAR The draft workplan will be formally adopted later in 2021. CDC participates in TATFAR as a U.S. member agency and as the Taskforce Secretariat.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe